Long Focus Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.7M Sell
490,200
-960,000
-66% -$85.7M 1.3% 24
2026
Q1
$104M Buy
1,450,200
+320,000
+28% +$24.7M 2.74% 7
2025
Q4
$89.7M Sell
1,130,200
-330,000
-23% -$26M 2.36% 8
2025
Q3
$110M Buy
1,460,200
+369,700
+34% +$25.3M 3.64% 3
2025
Q2
$75.2M Sell
1,090,500
-310,000
-22% -$20.3M 2.84% 7
2025
Q1
$94.9M Sell
1,400,500
-331,900
-19% -$19.9M 3.17% 5
2024
Q4
$77.8M Buy
+1,732,400
New +$97.2M 2.52% 7

Other funds holding CVS

Long Focus Capital Management's CVS Position: Q2 2026 in Review

Long Focus Capital Management reduced its CVS Health (CVS) stake by 34% in Q2 2026, selling an estimated $27.5M and leaving 586,000 shares worth $60.6M. The position accounts for 1.55% of the portfolio, ranked #15.

Long Focus Capital Management first reported a position in CVS in Q4 2021 and has held it in 8 quarters since. The position peaked at $70.5M in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Long Focus Capital Management held 586,000 shares of CVS Health worth $60.6M as of Q2 2026.
  • Long Focus Capital Management sold 308,000 CVS Health shares in Q2 2026, an estimated $27.5M.
  • CVS Health made up 1.55% of Long Focus Capital Management's portfolio in Q2 2026, its #15 holding.
  • Long Focus Capital Management first reported a position in CVS Health in Q4 2021 and has held it in 8 quarters since.
  • Long Focus Capital Management's CVS Health position peaked at $70.5M in Q1 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Long Focus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.